19-46746401-G-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_013403.3(STRN4):​c.30C>A​(p.Val10Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.003 in 1,060,528 control chromosomes in the GnomAD database, including 73 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 34 hom., cov: 29)
Exomes 𝑓: 0.0012 ( 39 hom. )

Consequence

STRN4
NM_013403.3 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.763

Publications

0 publications found
Variant links:
Genes affected
STRN4 (HGNC:15721): (striatin 4) Enables armadillo repeat domain binding activity and protein phosphatase 2A binding activity. Part of FAR/SIN/STRIPAK complex. [provided by Alliance of Genome Resources, Apr 2022]
FKRP (HGNC:17997): (fukutin related protein) This gene encodes a protein which is targeted to the medial Golgi apparatus and is necessary for posttranslational modification of dystroglycan. Mutations in this gene have been associated with congenital muscular dystrophy, cognitive disability, and cerebellar cysts. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Oct 2008]
FKRP Gene-Disease associations (from GenCC):
  • autosomal recessive limb-girdle muscular dystrophy type 2I
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, G2P, Ambry Genetics
  • muscular dystrophy-dystroglycanopathy type B5
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Myriad Women’s Health, Labcorp Genetics (formerly Invitae)
  • myopathy caused by variation in FKRP
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • congenital muscular dystrophy with cerebellar involvement
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital muscular dystrophy with intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital muscular dystrophy without intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • muscle-eye-brain disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 19-46746401-G-T is Benign according to our data. Variant chr19-46746401-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 781468.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.763 with no splicing effect.
BA1
GnomAdExome4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0516 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STRN4NM_013403.3 linkc.30C>A p.Val10Val synonymous_variant Exon 1 of 18 ENST00000263280.11 NP_037535.2 Q9NRL3-1
FKRPNM_024301.5 linkc.-253+311G>T intron_variant Intron 1 of 3 ENST00000318584.10 NP_077277.1 Q9H9S5A0A024R0R7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STRN4ENST00000263280.11 linkc.30C>A p.Val10Val synonymous_variant Exon 1 of 18 1 NM_013403.3 ENSP00000263280.4 Q9NRL3-1
FKRPENST00000318584.10 linkc.-253+311G>T intron_variant Intron 1 of 3 1 NM_024301.5 ENSP00000326570.4 Q9H9S5

Frequencies

GnomAD3 genomes
AF:
0.0142
AC:
2081
AN:
146962
Hom.:
34
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.0490
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00444
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000106
Gnomad OTH
AF:
0.00791
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
26
AF XY:
0.00
Gnomad NFE exome
AF:
0.00
GnomAD4 exome
AF:
0.00121
AC:
1103
AN:
913458
Hom.:
39
Cov.:
33
AF XY:
0.00112
AC XY:
479
AN XY:
427902
show subpopulations
African (AFR)
AF:
0.0544
AC:
959
AN:
17614
American (AMR)
AF:
0.00513
AC:
18
AN:
3512
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
7606
East Asian (EAS)
AF:
0.00
AC:
0
AN:
8774
South Asian (SAS)
AF:
0.000280
AC:
5
AN:
17870
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
8238
Middle Eastern (MID)
AF:
0.00245
AC:
5
AN:
2044
European-Non Finnish (NFE)
AF:
0.0000147
AC:
12
AN:
815550
Other (OTH)
AF:
0.00322
AC:
104
AN:
32250
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
50
100
150
200
250
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0141
AC:
2081
AN:
147070
Hom.:
34
Cov.:
29
AF XY:
0.0138
AC XY:
989
AN XY:
71700
show subpopulations
African (AFR)
AF:
0.0488
AC:
1992
AN:
40786
American (AMR)
AF:
0.00443
AC:
66
AN:
14894
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3390
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5006
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4810
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
8942
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000106
AC:
7
AN:
66000
Other (OTH)
AF:
0.00782
AC:
16
AN:
2046
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
98
196
294
392
490
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00971
Hom.:
1

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 26, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
7.2
DANN
Benign
0.86
PhyloP100
-0.76
PromoterAI
-0.055
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs569440158; hg19: chr19-47249658; API